Jian-Hong Peng (Jianhong Peng)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Locally Advanced

Ejection Fraction

Top Venues

Therapeutic advances in medical oncology

Cancer communications (London, England)

Gastroenterology report

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jian-Hong Peng, Wei-Li Zhang, Jiahua He, Weifeng Wang, Weihao Li, Lijun Mao, Yuejin Dong, Zhenhai Lu, Zhizhong Pan, Chi Zhou, Xiaojun Wu
Combination of DNA ploidy, stroma, and nucleotyping predicting prognosis and tailoring adjuvant chemotherapy duration in stage III colon cancer. Therapeutic advances in medical oncology 16 (2024)
Jian-Hong Peng, Wei-Li Zhang, Jiahua He, Weifeng Wang, Weihao Li, Lijun Mao, Yuejin Dong, Zhenhai Lu, Zhizhong Pan, Chi Zhou, Xiaojun Wu
Combination of DNA ploidy, stroma, and nucleotyping predicting prognosis and tailoring adjuvant chemotherapy duration in stage III colon cancer. Therapeutic advances in medical oncology 16 (2024)
Weiwei Xiao, Keng-Jian Ke, Wei-Li Zhang, Ling-Yan Wang, Yan-Ping Wu, Fan Weng, Huan Tian, Zhi-Yu Qiu, Yin Li, Shi-Yong Lin, Mei-Xian Ye, Qing-Jian Ou, Cheng-Hua Gong, Zhen-Hai Lu, Zhi-Zhong Pan, De-Sen Wan, Jian-Hong Peng, Yu-Jing Fang
Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms. Cancer medicine 11 (22) (2022)
Junzhong Lin, Hui Sun, Wei-Li Zhang, Zhigang Hong, Zhenhai Lu, Zhizhong Pan, Zhenlin Hou, Jian-Hong Peng
Conversion therapy with the intent to perform radical local treatment may not be suitable for patients with 10 or more liver metastases from colorectal cancer. Cancer medicine 11 (22) (2022)
Jian-Hong Peng, Yujun Liu, Weihao Li, Yuzhu Lin, Hui Sun, Zhizhong Pan, Xiaojun Wu, Wenhua Fan, Junzhong Lin
Application of Tumor Burden Score for predicting conversion outcome in patients with initially unresectable colorectal liver metastases after first-line systemic therapy. Therapeutic advances in gastroenterology 14 (2021)
Jian-Hong Peng, Yi Tai, Yi-Xin Zhao, Bao-Jia Luo, Qing-Jian Ou, Zhi-Zhong Pan, Lin Zhang, Zhen-Hai Lu
Programmed death-ligand 1 expression in the tumour stroma of colorectal liver oligometastases and its association with prognosis after liver resection. Gastroenterology report 9 (5) (2020)
Bin-Yi Xiao, Jian-Hong Peng, Jinghua Tang, Yuxiang Deng, Yujie Zhao, Xiaojun Wu, Peirong Ding, Junzhong Lin, Zhizhong Pan
Serum Gamma Glutamyl transferase is a predictor of recurrence after R0 hepatectomy for patients with colorectal cancer liver metastases. Therapeutic advances in medical oncology 12 (2020)
Jian-Hong Peng, Qingjian Ou, Yuxiang Deng, Bin-Yi Xiao, Lin Zhang, Jibin Li, Yin Li, Desen Wan, Zhenhai Lu, Yujing Fang
TROP2 overexpression in colorectal liver oligometastases is associated with poor prognosis after liver resection. Therapeutic advances in medical oncology 11 (2019)
Jian-Hong Peng, Jun-Zhong Lin, Yu-Ming Rong, Ying Zhu, Yu-Xiang Deng, Yu-Jie Zhao, Zhen-Hai Lu, Xiao-Jun Wu, Zhi-Zhong Pan
Oxaliplatin-containing adjuvant chemotherapy improves the survival of locally advanced rectal cancer patients with pathological complete response after pre-operative chemoradiotherapy. Gastroenterology report 6 (3) (2018)
Zhizhong Pan, Jian-Hong Peng, Junzhong Lin, Gong Chen, Xiaojun Wu, Zhenhai Lu, Yuxiang Deng, Yujie Zhao, Qiaoqi Sui, Desen Wan
Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection? Cancer communications (London, England) 38 (1) (2018)
Fulong Wang, Wenhua Fan, Jian-Hong Peng, Zhenhai Lu, Zhizhong Pan, Liren Li, Yuanhong Gao, Hui Li, Gong Chen, Xiaojun Wu, Peirong Ding, Zhifan Zeng, Desen Wan
Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial. Cancer communications (London, England) 38 (1) (2018)